ASP Isotopes prices $210.3M underwritten public offering

ASP Isotopes (ASPI) announced the pricing of an underwritten public offering of 17,167,380 shares of its common stock for total gross proceeds of approximately $210.3M, before deducting underwriting discounts and commissions and estimated offering expenses payable by the Company. The offering is expected to close on October 16, 2025, subject to satisfaction of customary closing conditions. All of the shares of common stock in the offering will be sold by the Company. In addition, the Company has granted the underwriters a 30-day option to purchase approximately $31.5M of additional shares of its common stock offered in the public offering, at the offering price, less underwriting discounts and commissions. Cantor and Lucid Capital Markets acted as joint book-running managers for the offering. The underwriters may offer the shares from time to time for sale in one or more transactions on the Nasdaq Capital Market, in the over-the-counter market, through negotiated transactions or otherwise at market prices prevailing at the time of sale, at prices related to prevailing market prices or at negotiated prices. On October 14, 2025, the last sale price of the shares as reported on the Nasdaq Capital Market was $14.05 per share. The Company intends to use the net proceeds from this offering for general corporate purposes, including working capital, operating expenses, and capital expenditures.